Jeff Jones, MD
Interventional Pain Medicine · Modesto, CANPI 1669483616
Payments from drug & device makers
Across 186 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Histosonics, Inc.$867
- Electronic Waveform Lab, Inc.$579
- Collegium Pharmaceutical, Inc.$327
- Nevro Corp.$318
- Boston Scientific$229
- Medtronic$203
- plus $2K from 31 others
What the payments were for
- Travel & lodging$86721%
- Food & beverage$3,32079%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Histosonics, Inc. | 1 | $867 |
| Electronic Waveform Lab, Inc. | 22 | $579 |
| Collegium Pharmaceutical, Inc. | 20 | $327 |
| Nevro Corp. | 16 | $318 |
| Boston Scientific | 13 | $229 |
| Medtronic(2 entities) | 8 | $203 |
| Tersera Therapeutics LLC | 17 | $191 |
| Pfizer | 22 | $171 |
| Scilex Pharmaceuticals Inc. | 7 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $114 |
| Biodelivery Sciences International, Inc. | 7 | $110 |
| Forte Bio-pharma LLC | 3 | $104 |
| Painteq LLC | 3 | $103 |
| Abbott | 4 | $100 |
| MDD US Operations, LLC | 4 | $61 |
| Redhill Biopharma Inc. | 4 | $61 |
| Bioventus LLC | 3 | $52 |
| Johnson & Johnson | 2 | $49 |
| Stimwave Technologies Incorporated | 3 | $45 |
| Flowonix Medical Incorporated | 1 | $41 |
| Vertex | 2 | $37 |
| AbbVie | 2 | $29 |
| Indivior Inc. | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Abiomed | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Vertos Medical, Inc. | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Piramal Critical Care | 1 | $13 |
| Orthogenrx Inc. | 1 | $13 |
How this compares
$4,187 in reported general payments places this provider in the 55th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 32 | $4,805 |
| Buprenorphine Hcl | 59 | $2,519 |
| Gabapentin | 37 | $802 |
| Naloxone Hcl | 12 | $710 |
| Cyclobenzaprine Hcl | 40 | $628 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $613 |
| Tizanidine Hcl | 39 | $425 |
| Tramadol Hcl | 36 | $288 |
| Pregabalin | 15 | $196 |
| Duloxetine Hcl | 14 | $142 |
| Ibuprofen | 14 | $108 |
| Lorazepam | 11 | $71 |
| Alprazolam | 18 | $66 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Modesto
- Markus JacksonModesto$20K
- Sheldon JordanSanta Monica$3.1M
- Ezekiel FinkBeverly Hills$2.3M
- Matthew DotyOroville$1.3M
- Tim LeierRancho Mirage$749K
- Pragya GuptaEscondido$647K
- Michael Verdolinla Mesa$563K
- Standiford HelmOrange$476K
- Patrick BuchananCamarillo$453K
- Roy BrownlowSan Diego$452K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.